Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S.Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections ReportedThe US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu VaccineThe U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life SciencesModerna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Must-Reads
1
Why Some People Gain Weight on Salads—and Others Don’t
LIFESTYLE
2
This Vitamin Could Help You Fight Fatigue, Infections, and More
LIFESTYLE
3
Olive Oil on an Empty Stomach – Hype or Health Miracle?
LIFESTYLE
4
Why Guava Is a Must-Have for Anyone Watching Their Blood Sugar
LIFESTYLE
5
Parkinson's Puzzle: Study Explains How PINK1 Gene Fights Cell Damage
Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S. Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections Reported The US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu Vaccine The U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life Sciences Moderna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Hot Topics